Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines - Related Studies

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

This study is ongoing, but not recruiting participants.

Study NCT00001512. Last updated on June 19, 2006. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		B Cell Lymphoma
		Follicular Lymphoma
		Lymphoma

2	Additional conditions recognized in this trial
		Lymphoma, B-Cell
		Lymphoma, Follicular

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoma, Non-Hodgkin
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		Id-KLH Vaccine
		GM-CSF

5	Additional drug interventions recognized in this trial
		Immunoglobulin Idiotypes
		Immunoglobulins

6	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		National Cancer Institute (NCI)